{
    "clinical_study": {
        "@rank": "97580", 
        "arm_group": [
            {
                "arm_group_label": "Standard", 
                "arm_group_type": "Experimental", 
                "description": "Fixed protocol"
            }, 
            {
                "arm_group_label": "Individualized", 
                "arm_group_type": "Experimental", 
                "description": "Individualized protocol"
            }, 
            {
                "arm_group_label": "Control", 
                "arm_group_type": "Sham Comparator", 
                "description": "Sham acupuncture/Placebo moxa"
            }
        ], 
        "brief_summary": {
            "textblock": "The objective of this study is to test the efficacy of a symptom management treatment\n      strategy, Acupuncture/Moxibustion (Acu/Moxa), to improve the symptoms associated with\n      Irritable Bowel Syndrome (IBS) in adults."
        }, 
        "brief_title": "Symptom Management for Irritable Bowel Syndrome", 
        "condition": "Irritable Bowel Syndrome", 
        "condition_browse": {
            "mesh_term": "Irritable Bowel Syndrome"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Men and women 18 to 70 years of age.\n\n          -  Diagnosis of IBS based on ROME III criteria.\n\n          -  Complete symptom diaries and return completed diaries at all sessions.\n\n        Exclusion Criteria:\n\n          -  History of co-existing gastrointestinal, and/or gynecological, and/or urologic\n             pathology.\n\n          -  Alarm symptoms according to ROME III.\n\n          -  Individuals currently receiving other types of complementary therapies.\n\n          -  Individuals with an acute medical condition requiring acute medical attention."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "183", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 3, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02079857", 
            "org_study_id": "S12-02325", 
            "secondary_id": "R01NR013695"
        }, 
        "intervention": [
            {
                "arm_group_label": "Standard", 
                "description": "Subjects will receive a standard treatment", 
                "intervention_name": "Standard protocol", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Individualized", 
                "description": "Subjects will receive an individualized treatment", 
                "intervention_name": "Individualized protocol", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Control", 
                "description": "Subjects will receive sham acupuncture/placebo moxa", 
                "intervention_name": "Sham acupuncture/Placebo moxa", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 6, 2014", 
        "location": {
            "contact": {
                "last_name": "Colin Scully", 
                "phone": "212-992-7051"
            }, 
            "facility": {
                "address": {
                    "city": "New York", 
                    "country": "United States", 
                    "state": "New York", 
                    "zip": "10010"
                }, 
                "name": "NYU Division of Special Studies in Symptom Management"
            }, 
            "investigator": {
                "last_name": "Dr. Joyce K Anastasi, PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "3", 
        "official_title": "Symptom Management for Irritable Bowel Syndrome", 
        "overall_official": {
            "affiliation": "New York University", 
            "last_name": "Dr. Joyce K Anastasi, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "Symptom severity-abdominal pain", 
                "safety_issue": "No", 
                "time_frame": "week 1"
            }, 
            {
                "measure": "Symptom severity-abdominal pain", 
                "safety_issue": "No", 
                "time_frame": "week 4"
            }, 
            {
                "measure": "Symptom severity-abdominal pain", 
                "safety_issue": "No", 
                "time_frame": "week 8"
            }, 
            {
                "measure": "Symptom severity-abdominal pain", 
                "safety_issue": "No", 
                "time_frame": "week 12"
            }, 
            {
                "measure": "Symptom severity-abdominal pain", 
                "safety_issue": "No", 
                "time_frame": "week 24"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02079857"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "New York University School of Medicine", 
        "sponsors": {
            "collaborator": {
                "agency": "National Institute of Nursing Research (NINR)", 
                "agency_class": "NIH"
            }, 
            "lead_sponsor": {
                "agency": "New York University School of Medicine", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2012", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}